Polypeptides from non-typeable Haemophilus influenzae
    5.
    发明授权
    Polypeptides from non-typeable Haemophilus influenzae 有权
    来自不可分型流感嗜血杆菌的多肽

    公开(公告)号:US08124098B2

    公开(公告)日:2012-02-28

    申请号:US12800898

    申请日:2010-05-25

    IPC分类号: A61K39/02 C07H21/04 C07K14/00

    摘要: Polypeptides comprising non-typeable Haemophilus influenzae (NTHi) amino acid sequences. Over 2500 specific NTHi proteins are disclosed. The invention also provides related polypeptides, nucleic acids, antibodies and methods. These can all be used in medicine for treating or preventing disease and/or infection caused by H. influenzae, such as otitis media.

    摘要翻译: 包含不可分型流感嗜血杆菌(NTHi)氨基酸序列的多肽。 公开了超过2500种特异性NTHi蛋白。 本发明还提供了相关的多肽,核酸,抗体和方法。 这些都可以用于治疗或预防由流感嗜血杆菌引起的疾病和/或感染的药物,例如中耳炎。

    Lactoferrin Cleavage of Neisserial Proteins
    7.
    发明申请
    Lactoferrin Cleavage of Neisserial Proteins 失效
    乳铁蛋白裂解奈瑟氏球蛋白

    公开(公告)号:US20080193971A1

    公开(公告)日:2008-08-14

    申请号:US11587191

    申请日:2005-04-28

    CPC分类号: A61K39/095 C07K14/22

    摘要: Meningococcal antigens are cleaved by human lactoferrin. The invention is based on the identification of the cleavage products of this reaction, and provides a method for cleaving a neisserial polypeptide, comprising the step of mixing the polypeptide with a lactoferrin enzyme. The invention also provides polypeptides obtainable by this process (i.e. the cleavage products of the lactoferrin digestion) which might be useful in the preparation of anti-meningococcal vaccines. Proteins of particular interest are meningococcal proteins 287 and App.

    摘要翻译: 脑膜炎球菌抗原被人乳铁蛋白切割。 本发明基于该反应的切割产物的鉴定,并提供了切割奈司多肽的方法,包括将多肽与乳铁蛋白酶混合的步骤。 本发明还提供可通过该方法获得的多肽(即乳铁蛋白消化的切割产物),其可用于制备抗脑膜炎球菌疫苗。 特别感兴趣的蛋白质是脑膜炎球菌蛋白质287和App。

    MENINGOCOCCUS ADHESINS NADA, APP AND ORF 40
    10.
    发明申请
    MENINGOCOCCUS ADHESINS NADA, APP AND ORF 40 审中-公开
    MENINGOCOCCUS ADHESINS NADA,APP和ORF 40

    公开(公告)号:US20100221256A1

    公开(公告)日:2010-09-02

    申请号:US12775457

    申请日:2010-05-06

    摘要: NadA, App and ORF40 function as adhesins in N. meningitidis. Adhesion can be modulated by targeting these three proteins. NadA allelic variants are disclosed. Autoproteolytic cleavage of App is disclosed, as is removal of the activity by mutagenesis. App is processed and secreted into culture medium when expressed in E. coli. Mature App proteins are disclosed. Knockout mutants are disclosed. Vesicles from non-Neisserial hosts with heterologous adhesin expression are disclosed.

    摘要翻译: NadA,App和ORF40作为脑膜炎奈瑟氏球菌中的粘附素起作用。 可以通过靶向这三种蛋白来调节粘附。 公开了NadA等位基因变体。 公开了App的自体蛋白水解切割,以及通过诱变去除活性。 当在大肠杆菌中表达时,将APP加工并分泌到培养基中。 公开了成熟的App蛋白质。 揭示突变突变体。 公开了具有异源粘附素表达的非奈及利主体的囊泡。